SaltStick Caps Plus
Natural health product licensed in Canada
- Licence holder
- Alete Active Nutrition
- NPN or DIN-HM
- 80085537
- Status
- Active licence
- Licence date
- 25 May 2018
- Revision date
- 26 February 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Potassium: up to 742 mg a day according to the dosing instructions published by Health Canada (14 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 80 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sodium Source : Citrate de sodium | 190 mg | Not calculated |
| Potassium Source : Chlorure de potassium | 53 mg | 742,000 µg |
| Potassium Source : Citrate de potassium | 53 mg | 742,000 µg |
| Calcium Source : Chlorure de calcium | 14 mg | 196,000 µg |
| Calcium Source : Gluconate de calcium | 14 mg | 196,000 µg |
| Magnésium Source : Gluconate de magnésium | 7 mg | 98,000 µg |
| Magnésium Source : Citrate de magnésium | 7 mg | 98,000 µg |
| 3,7-dihydro-1,3,7-triméthyl-1H-purine-2,6-dione Source : Caféine | 30 mg | Not calculated |
| Chlorure (ion) Source : Chlorure de calcium | 50 mg | Not calculated |
| Chlorure (ion) Source : Chlorure de potassium | 50 mg | Not calculated |
Non-medicinal ingredients
L-Leucine, Hypromellose, dérivé sodium-cuivre de la chlorophylline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | minimum: 1 day ; maximum: 7 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of electrolytes during/after prolonged (>1 hour) exercise, intermittent high intensity exercise, or exercise in hot conditions. Helps to temporarily relieve fatigue, to promote endurance, and to enhance motor performance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80085537
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.